Report
Christophe-Raphaël Ganet

Bastide : Feedback from analysts' meeting: one year of financial discipline - set for a corporate catalyst for debt deleveraging/disposals?

>Organic and cash focus for 2023-24 - Our discussions with the company highlighted three main points:1/ Growth and margins. Bastide is targeting revenues of € 540m in 2023-24.Bastide said it would benefit from i/ persistently healthy demand, particularly internationally (>+10% est.), and in France in healthcare services (e.g. diabetes and the structuring of the dedicated team), ii/ a more modest consolidation effect (three deals including Probace and 4Se-Med...
Underlying
Bastide Le Confort Medical SA

Bastide le Confort Medical is a holding company. Through its subsidiaries, Co. is engaged in the home health care industry. Co. retails and rents medical equipment and provides medical services. Products include breathing apparatus, orthopedic shoes, walking aids and wheelchairs, home appliances and furniture adapted to the needs of the lesser able, with the recent addition of equipment related to perfusion and nutrition. Co. operates through a number of outlets concentrated mainly in the South of France, offering advice and information to customers along with the provision and maintenance of medical equipment.

Provider
Oddo BHF
Oddo BHF

​Oddo Securities provides securities brokerage and research services. The company offers equity, economic, and derivatives research and credit analysis services. It focuses on insurance, automotive, building materials, pharmaceuticals, telecommunications, information technology, and agri-food industries.

Analysts
Christophe-Raphaël Ganet

Other Reports on these Companies
Other Reports from Oddo BHF

ResearchPool Subscriptions

Get the most out of your insights

Get in touch